7,528.75

-45.50

-0.60%

52,409.00

-89.00

-0.17%

27,721.75

-292.75

-1.04%

Russell 2000 Futures

2,822.40

-26.30

-0.92%

4.9500

+0.0860

+1.77%

21.15

+1.23

+6.17%

4,066.30

-48.20

-1.17%

73,866.75

-920.75

-1.23%

Crude Oil Dec 26

84.62

-2.23

-2.57%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

XTL Biopharmaceuticals Ltd. (XTLB)

1.5301 -0.0199 (-1.28%)

At close: November 9 at 4:00:00 PM EST

Loading Chart for XTLB

Chart Range Bar

Interval:

In partnership with ChartIQ

XTL Completed the Acquisition of Psyga Bio Ltd.

XTL Completed the Acquisition of Psyga Bio Ltd.

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

XTL Biopharmaceuticals Announces ADS Ratio Change

XTL Biopharmaceuticals Announces ADS Ratio Change

XTL Update on Recent Developments

XTL Update on Recent Developments

Top Midday Gainers

Top Midday Gainers

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Mobilize your Website

View Site in Mobile | Classic

Share by: